⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AUTL News
Autolus Therapeutics plc American Depositary Share
Form 8-K
sec.gov
AUTL
Autolus Therapeutics Announces Initiative to Support Operational Efficiency and Cost Reduction
globenewswire.com
AUTL
Peripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
globenewswire.com
MRK
IPHA
VERU
KURA
INCY
AMGN
PFE
GILD
REGN
AZN
CRSP
BIIB
NTRA
ALLO
KYMR
ADCT
IMUX
CELC
ONON
ABBV
TDOC
BMY
IMVT
GNTX
IMPP
AUTL
Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
globenewswire.com
WVE
AUTL
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AUTL
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
globenewswire.com
AZN
CRSP
NKTR
INCY
IPHA
ABBV
BIIB
ALKS
IMVT
CLRB
IMPP
REGN
THO
AUTL
KYMR
CBIO
GILD
Form 8-K
sec.gov
AUTL
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative ‘personalized off-the-shelf’ immunotherapy toward clinical development
globenewswire.com
AUTL
AZN
Form 8-K
sec.gov
AUTL
Autolus Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
AUTL